化疗药理学和药理动力学对瘤回归和卡切西亚的二级影响
Luke Pierik1, Patricia McDonald2, Alexander R A Anderson3
1Center for Complex Biological Systems, University of California Irvine, Irvine, CA, USA.
改变化疗剂量变异,而不仅仅是总剂量,可以改善瘤反应. 高变异时间表可以保持瘦身量,减轻化疗诱导的缓解症,而不会降低治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 数学生物学 数学生物学
背景情况:
- 药物剂量反应曲线是癌症生物学中的标准,重点是累积剂量.
- 第二阶效应,如药物剂量变异,在治疗设计中经常被忽视.
- 优化化疗计划可以增强瘤反应并减少副作用.
研究的目的:
- 研究药物剂量变异 (二次效应) 对化疗结果的影响.
- 探索抗脆弱性理论和药理动力学如何影响治疗疗效.
- 评估高变量剂量的潜力,以保护瘦体质量和对抗缓解症.
主要方法:
- 利用扩展抗脆弱性理论的数学框架来模拟药物药理动力学.
- 采用一个单间模型来分析高变量时间表的有效性.
- 应用了小鼠参数化的5 - 甲两模型,以评估基于初始瘤体积的计划可行性.
主要成果:
- 高变异的药物剂量计划在一系列累积剂量中表现出有效性.
- 发现,化疗方案的可行性取决于最初的瘤体积.
- 数学建模表明,瘤反应和瘦肉质量保存之间存在权衡.
结论:
- 不同的药物剂量表,超出累积剂量,为改善癌症治疗提供了一种新的策略.
- 高变量剂量显示在保持瘦质量和减轻化疗相关的缓解症方面具有前景.
- 对剂量变异的进一步研究可以优化化疗方案,以获得更好的患者结果.
更多相关视频
09:19Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Cancer Survival Analysis
Treatment Resistant Cancers
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
